Influence of natalizumab on resting-state connectivity in patients with multiple sclerosis.

Diogo Goulart CorrêaEelco van DuinkerkenJoão Gabriel Dib FarinhasValéria C PereiraEmerson L GasparettoSoniza V Alves-LeonFernanda Cristina R Lopes

Published in: Journal of central nervous system disease (2023)

Differences in brain connectivity between MS patients not treated with natalizumab, healthy controls, and patients treated with natalizumab may be secondary to suboptimal neuronal compensation due to prior less efficient treatments, or due to a compensation in response to maladaptive plasticity.

Keyphrases

resting state
functional connectivity
multiple sclerosis
white matter
newly diagnosed
end stage renal disease
ejection fraction
mass spectrometry
prognostic factors
ms ms
blood brain barrier